Plasmid DNA- and messenger RNA-based anti-cancer vaccination
- 26 October 2007
- journal article
- review article
- Published by Elsevier in Immunology Letters
- Vol. 115 (1) , 33-42
- https://doi.org/10.1016/j.imlet.2007.09.012
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependentGene Therapy, 2007
- CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patientsBlood, 2005
- Human Clinical Trials of Plasmid DNA VaccinesAdvances in Genetics, 2005
- Messenger RNA-based vaccinesExpert Opinion on Biological Therapy, 2004
- Nonviral Approaches Satisfying Various Requirements for Effective in Vivo Gene Therapy.Biological & Pharmaceutical Bulletin, 2002
- Detection and quantification of CD8+ T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-?-elispot assayInternational Journal of Cancer, 2001
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screeningProceedings of the National Academy of Sciences, 1997
- Human neoplasms elicit multiple specific immune responses in the autologous host.Proceedings of the National Academy of Sciences, 1995
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990